![]() |
市场调查报告书
商品编码
1884040
自动验光仪和角膜曲率计市场规模、占有率、成长及全球产业分析:按类型、应用和地区划分的洞察与预测(2024-2032 年)Autorefractor and Keratometer Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
由于眼科疾病的增加、诊断设备的日益普及以及眼科医疗器材技术的创新,全球自动验光仪和角膜曲率计市场持续稳定成长。 2024 年,该市场价值为 6,970 万美元,预计到 2025 年将达到 7,330 万美元。预计到 2032 年,该市场将进一步飙升至 1.071 亿美元,反映了全球眼科诊疗业务的强劲成长。北美在 2024 年以 35% 的市占率领先,这得益于先进的医疗基础设施和主要公司不断扩大的诊断设备产品组合。
市场概览
自动验光仪和角膜曲率计是重要的眼科诊断设备,分别用于测量屈光不正和角膜曲率。组合式自动验光-角膜曲率计(ARK)可对远视、近视、散光和其他屈光不正进行全面的视力评估。由于全球视力障碍负担日益加重以及对早期检测的日益重视,对这些设备的需求正在稳步增长。
市场由主要製造商支撑,包括拓普康公司、卡尔蔡司医疗技术股份公司、尼德克株式会社、佳能医疗系统和依视路陆逊梯卡集团,这些製造商都在大力投资技术创新和产品拓展策略。
市场驱动因素
眼科疾病的成长趋势
散光、远视和白内障等眼科疾病的盛行率正在加速上升。生活方式的改变、萤幕使用时间的增加以及与年龄相关的眼部退化,促使越来越多的人需要视力矫正。根据美国国家生物技术资讯中心 (NCBI) 2023 年 9 月发布的报告预测,到 2050 年,全球约 50% 的人口将患有近视,其中 10% 预计为高度近视。应对这一日益严重的负担需要先进的眼科诊断解决方案,从而推动了对自动验光仪和角膜曲率计的需求。
促进早期准确诊断
各国政府和医疗机构正在加大对早期检测项目的投入,以控制可预防的失明。早期筛检屈光不正有助于适当的治疗,这无疑将推动对先进眼科设备的需求。
市场限制因子
发展中国家面临的主要挑战包括对定期眼科检查的认知不足以及经济能力有限。正如 Bimedis (2025) 指出,自动验光仪价格高昂,通常高达 25,000 美元,这使得小型诊所难以负担,从而减缓了其在成本敏感地区的市场渗透。一些国家缺乏训练有素的眼科技术人员也是促使设备利用率低的原因之一。
市场机会
大型公司之间的策略联盟正在加速创新。 2024 年 4 月,卡尔蔡司医疗科技公司收购了 D.O.R.C.,从而增强了其眼科工作流程和产品组合。预计此类联盟将支援推出更先进的设备,包括便携式和人工智慧系统,从而在 2032 年前创造强劲的成长机会。
市场趋势
数位影像、人工智慧诊断、机器学习、自动对焦、云端资料储存和电子健康记录 (EHR) 整合等技术创新正在改变整个产业。现代设备能够捕捉高解析度角膜影像,检测细微的解剖结构变化,并提供自动化结果,从而提高临床准确性和效率。这些创新使自动角膜曲率计 (ARK) 成为现代眼科实践中不可或缺的工具。
依产品类型
按便携性
依适应症划分
根据克利夫兰诊所估计,到2024年,远视将占最大的市场占有率,影响全球4.6%的儿童和30.9%的成人。由于萤幕使用时间的增加,近视和散光的盛行率预计将显着上升。
依最终使用者划分
儘管由于手术量大,医院在2024年仍将占市场主导地位,但由于专业眼科诊所的扩张,预计眼科诊所将增长最快。
依地区划分
北美
受美国和加拿大高渗透率的推动,预计到2024年,北美市场规模将达到2,440万美元。糖尿病的高发生率和日益增长的眼部併发症正在推动对精准诊断工具的需求。
欧洲
由于严格的医疗器材监管和庞大的眼科医师群体,欧洲市场保持强劲成长。截至2023年12月,英国共有3,377名註册眼科医师。
亚太地区
预计将以最高的复合年增长率成长。屈光不正病例的增加,例如南德里学龄儿童散光盛行率高达47.8%(2022年),正在推动先进诊断技术的需求。
拉丁美洲/中东/非洲
由于医疗保健投资,包括沙乌地阿拉伯耗资650亿美元的 "2030愿景" 健康计划,预计将实现温和成长。
The global autorefractor and keratometer market continues to expand steadily due to rising ophthalmic disorders, increasing adoption of diagnostic equipment, and strong technological advancements in eye-care devices. The market was valued at USD 69.7 million in 2024, is expected to reach USD 73.3 million in 2025, and is projected to surge to USD 107.1 million by 2032, reflecting strong growth across ophthalmic practices worldwide. North America led the market in 2024 with a 35% share, supported by advanced healthcare infrastructure and major players expanding their diagnostic portfolios.
Market Overview
Autorefractors and keratometers are essential ophthalmic diagnostic instruments used to measure refractive error and corneal curvature, respectively. Combined units, known as autorefractor-keratometers (ARKs), provide comprehensive vision assessment for hyperopia, myopia, astigmatism, and other refractive issues. Demand for these devices is steadily rising due to the global burden of vision disorders and increased emphasis on early detection.
The market is supported by leading manufacturers such as Topcon Corporation, Carl Zeiss Meditech AG, NIDEK CO., LTD., Canon Medical Systems, and EssilorLuxottica, all investing heavily in technology advancements and product expansion strategies.
Market Drivers
Growing Burden of Eye Disorders
The prevalence of ocular diseases such as astigmatism, hyperopia, and cataracts is accelerating. Lifestyle changes, increased screen time, and age-related degeneration contribute to a growing population requiring vision correction. According to NCBI (September 2023), nearly 50% of the global population is expected to have myopia by 2050, with 10% becoming highly myopic. This rising burden necessitates advanced eye-diagnostic solutions, boosting demand for autorefractors and keratometers.
Push for Early and Accurate Diagnosis
Governments and healthcare institutions are increasing investments in early detection programs to manage preventable blindness. Early refractive error screening allows timely treatment, positively raising the demand for advanced ophthalmic equipment.
Market Restraints
A key challenge in developing economies is limited awareness regarding regular eye examinations, combined with affordability issues. High-end autorefractors costing up to USD 25,000, as cited by Bimedis (2025), are often unaffordable for smaller clinics, slowing market penetration in cost-sensitive regions. The lack of trained ophthalmic technicians in several countries also reduces device utilization.
Market Opportunities
Strategic collaborations among major players are accelerating innovation. In April 2024, Carl Zeiss Meditech acquired D.O.R.C., strengthening its ophthalmic workflow and product portfolio. Such partnerships support the launch of more advanced devices, including handheld and AI-enabled systems, creating strong growth opportunities through 2032.
Market Trends
Technological advancements-including digital imaging, AI-powered diagnostics, machine learning, automated focusing, cloud data storage, and EHR integration-are reshaping the industry. Modern devices can capture high-resolution corneal images, detect subtle anatomical changes, and provide automated results, improving clinical accuracy and efficiency. These innovations are positioning ARKs as indispensable tools in modern eye-care practices.
By Product Type
By Portability
By Indication
Hyperopia held the largest share in 2024, with Cleveland Clinic estimating it affects 4.6% of children and 30.9% of adults globally. Myopia and astigmatism are expected to grow significantly due to increased screen exposure.
By End User
Hospitals dominated in 2024 due to high procedure volume, while ophthalmic clinics are growing fastest with the expansion of specialty eye-care centers.
Regional Overview
North America
The region generated USD 24.4 million in 2024, driven by strong adoption in the U.S. and Canada. High diabetic population rates and increased ocular complications are pushing demand for precision diagnostic tools.
Europe
Europe maintains a strong market due to strict medical device regulations and a large ophthalmologist base. The U.K. had 3,377 ophthalmologists registered in December 2023.
Asia Pacific
Expected to grow at the fastest CAGR. Rising cases of refractive errors-such as 47.8% astigmatism in South Delhi school children (2022)-are driving demand for advanced diagnostics.
Latin America & Middle East/Africa
Moderate growth driven by healthcare investments, including Saudi Arabia's USD 65B Vision 2030 health program.
Conclusion
With a rise from USD 69.7 million (2024) to USD 107.1 million by 2032, the autorefractor and keratometer market is poised for strong, sustained growth. Increasing ocular diseases, technological advancements, and expanding healthcare infrastructure worldwide will continue to propel the market through the forecast period.
Segmentation By Product Type
By Portability
By Indication
By End-user
By Region